Jamjoom Pharmaceuticals Factory Company Total Liabilities

Jamjoom Pharmaceuticals Factory Company (4015.SR) currently reports a total liabilities of $460M as of June 2026. That compares with $400M in the prior-year period — up 15.1% year over year. Use the charts on this page to explore Jamjoom Pharmaceuticals Factory Company's total liabilities history and peer comparisons.

Jamjoom Pharmaceuticals Factory Company's total liabilities increased from $400M to $460M — a 15.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Jamjoom Pharmaceuticals Factory Company reported $460M in total liabilities as of June 2026. That compares with $400M in the prior-year period — up 15.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $460M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Jamjoom Pharmaceuticals Factory Company, and consider following 4015.SR for alerts when major investors trade the stock.